The governing principle of spinal cord injury is similar to that of traumatic brain injury: the mechanical injury has already occurred, but the final neurologic deficit has not necessarily been determined. What changes is the pressure compartment. The brain is enclosed by skull and dura; the spinal cord is enclosed by bone, ligaments, dura, and a subarachnoid space that can become locally obstructed by swollen neural tissue. The first-hours objective is therefore not merely to identify a fracture or assign an ASIA grade. It is to prevent hypoxemia, hypotension, venous congestion, continued compression, and treatment-induced injury while arranging definitive decompression and stabilization when indicated.

Primary spinal cord injury results from compression, contusion, distraction, laceration, or vascular disruption at the moment of trauma. Mechanical deformation ruptures axons and cell membranes, damages the microcirculation, and produces intramedullary hemorrhage, most prominently within the relatively vascular gray matter. The secondary cascade begins immediately. Sodium and calcium enter injured cells, potassium exits, glutamate accumulates, mitochondria fail, reactive oxygen species form, capillaries thrombose or become permeable, and inflammatory cells amplify tissue injury. Cord edema then expands within a dural and osseous compartment that may have little residual compliance. The swollen cord can obstruct its own subarachnoid space and compress its microvascular supply, converting an initial contusion into progressive ischemic injury. This is why oxygenation, perfusion, and decompression are biologically linked rather than independent boxes on a trauma checklist. The physiology is well established, even though the clinical evidence supporting many specific thresholds remains weak (Ahuja et al., 2017).

The initial encounter begins with spinal motion restriction, not with sacrificing resuscitation to achieve absolute immobility. Maintain neutral alignment, use manual in-line stabilization during airway manipulation, minimize unnecessary transfers, and avoid forceful traction across an undefined injury. A necessary airway takes priority over obtaining a perfect neurologic examination, but when the patient is awake and physiologically stable, even a brief examination before paralytics, sedatives, or transport can preserve information that may never again be recoverable. The airway technique should be the one most likely to succeed on the first attempt while minimizing cervical motion; video laryngoscopy with manual stabilization is commonly appropriate, but no device compensates for prolonged hypoxemia or peri-intubation hypotension.

Cervical spinal cord injury can produce deceptively quiet respiratory failure. A patient may initially speak and maintain oxygen saturation while losing intercostal and abdominal muscle function, cough strength, and the ability to clear secretions. Lesions involving the phrenic motor system at C3 through C5 threaten diaphragmatic function directly, while lower cervical injuries may preserve the diaphragm but eliminate the accessory mechanics required to sustain ventilation. The trajectory matters more than a single saturation or arterial blood gas. Progressive tachypnea, paradoxical abdominal motion, declining vital capacity, rising carbon dioxide, weak cough, retained secretions, or fatigue should prompt early airway control rather than an emergency intubation after complete decompensation.

Hypotension in a trauma patient with spinal cord injury must initially be treated as hemorrhagic until bleeding has been reasonably excluded. Neurogenic shock is real, particularly after cervical or high thoracic injury, but it is a diagnosis made in the context of trauma resuscitation rather than an explanation that permits occult hemorrhage to be missed. Loss of descending sympathetic control produces arterial and venous dilation, reduced venous return, and often relative or absolute bradycardia. Warm extremities and a heart rate that seems inappropriately low for the blood pressure support the diagnosis, but neither feature is required. Pain, blood loss, hypoxemia, medications, and concomitant brain injury can all produce tachycardia in a patient who also has neurogenic vasodilation.

Once immediate threats are controlled, the neurologic examination should be converted from an impression into an International Standards for Neurological Classification of Spinal Cord Injury examination. The examination documents light touch and pinprick across the standard dermatomes, key-muscle strength in the upper and lower extremities, sensory and motor levels on each side, the overall neurological level of injury, and sacral function. Sacral sparing—not the presence of any movement somewhere below the lesion—is what distinguishes neurologically incomplete from complete injury. S4–S5 sensation, deep anal pressure, and voluntary anal contraction therefore carry disproportionate diagnostic importance. The bulbocavernosus reflex may help characterize spinal shock, but its absence is not the criterion for an AIS A injury.

A neurologically complete injury means that the standardized examination demonstrates no sensory or motor sacral sparing. It does not prove anatomical transection. Conversely, movement several segments below the injury does not automatically make an injury motor incomplete unless the ISNCSCI rules are fulfilled. Sedation, intoxication, pain, fractures, peripheral nerve injury, preexisting neuropathy, language barriers, and an unreliable rectal examination must be documented rather than silently converted into zeros. The baseline examination should be repeated after resuscitation, decompression, and withdrawal of confounders. Early conversion from one AIS grade to another may reflect genuine recovery, resolution of spinal shock, improved participation, or correction of an initially inaccurate examination. The revised 2019 ISNCSCI standard remains the appropriate framework.

Computed tomography is the first-line imaging modality for acute spinal trauma because it rapidly defines fractures, translation, retropulsion, facet disruption, and other features of instability. MRI answers a different set of questions: whether the cord is compressed or hemorrhagic, whether a traumatic disc has herniated, whether an epidural hematoma is present, and whether posterior ligamentous structures are disrupted. Intramedullary hemorrhage and long-segment cord signal abnormality generally indicate more severe injury, but MRI is not a deterministic prognostic test. The current ACR Appropriateness Criteria retain CT as initial imaging and support MRI when neurologic or ligamentous injury is suspected. MRI should inform operative planning when feasible, but obtaining it must not become an avoidable barrier to urgent decompression when the examination and available imaging already demonstrate a surgically remediable compressive lesion.

The most contested first-hours intervention is blood-pressure management. The physiologic argument is attractive. When autoregulation is impaired, spinal cord blood flow becomes pressure dependent. Raising MAP should increase the pressure driving blood through the injured microcirculation. Yet MAP is only the upstream systemic pressure. The more relevant quantity may be spinal cord perfusion pressure, approximated as MAP minus intrathecal pressure. A MAP of 85 mm Hg may be adequate when local intrathecal pressure is 10, but inadequate when swelling has raised pressure around the cord to 30. Conversely, forcing MAP to 95 may produce pulmonary edema, arrhythmia, myocardial stress, or increased intramedullary hemorrhage without improving tissue flow if vasoconstriction, microthrombosis, or local compression remains the dominant limitation.

The 2013 AANS/CNS recommendation to maintain MAP between 85 and 90 mm Hg for seven days became deeply embedded in spinal cord injury protocols despite being based largely on uncontrolled observational data. The 2024 AO Spine/Praxis guideline deliberately widened this target. It conditionally suggested augmenting MAP to at least 75–80 mm Hg as a lower boundary, avoiding active augmentation beyond approximately 90–95 mm Hg, and continuing support for three to seven days. The evidence for both the target and duration was rated very low, and the panel could not recommend a particular vasopressor or an SCPP target (Kwon et al., 2024). The range should therefore be understood as a zone for individualized management, not a mandate to drive every patient to 95.

The first randomized evidence has made indiscriminate augmentation even harder to defend. In 2025, a 13-center trial randomized 92 patients with cervical or upper-thoracic AIS A through C injuries to an augmented target above 85–90 mm Hg or a conventional target above 65–70 mm Hg for as long as seven days. The trial did not demonstrate better six-month motor or sensory recovery with augmentation. The augmented group had more respiratory complications—78% versus 39%—more pneumonia and pulmonary edema, approximately six additional days of mechanical ventilation on average, and higher noncardiovascular organ-failure scores. Interpretation requires discipline: only 38 patients completed the six-month assessment, 15 died, and the trial was underpowered. Moreover, the conventional group was not persistently hypotensive; its achieved MAP generally exceeded 75 mm Hg and averaged above 80 mm Hg. The trial therefore does not establish that MAP 65 is adequate. It suggests that preventing hypotension may be more important than maintaining vasopressor-driven MAP above 85–90 in every patient (Sajdeya et al., 2025).

A 2026 systematic review and meta-analysis of 33 studies and 3,535 patients reached a compatible conclusion. Across heterogeneous, predominantly observational cohorts, augmented MAP targets were not associated with statistically significant improvements in neurologic recovery or mortality, and no linear relationship between achieved MAP and neurologic outcome emerged. Respiratory complications were the clearest adverse signal. Certainty remained low because of heterogeneity, confounding by indication, and uneven denominators, but the aggregate evidence supports strict avoidance of hypotension rather than universal escalation to the historical 85–90 target (Kale et al., 2026).

Volume should restore euvolemia, not become the sole method of maintaining MAP for days. Hemorrhagic shock requires blood-product resuscitation and source control. Once volume is adequate, vasopressors are generally safer than continuing large crystalloid loads. Norepinephrine is commonly favored because its alpha effect restores vascular tone while modest beta activity supports cardiac output and may be advantageous in a bradycardic cervical injury. Phenylephrine can be useful when tachyarrhythmia limits beta stimulation, but pure alpha agonism may worsen reflex bradycardia and reduce cardiac output. Dopamine has historically been used but is associated with more tachyarrhythmias and myocardial complications, particularly in older patients. These preferences are based on physiology, animal work, and limited comparative data; the current guideline does not establish one agent as superior.

The analogy to cerebral perfusion has also driven interest in directly managing SCPP. Lumbar intrathecal pressure, however, may fail to represent pressure at the injury when swollen cord obliterates the intervening subarachnoid space. A 2026 prospective multicenter study inserted lumbar intrathecal catheters in 58 patients and attempted to maintain SCPP of at least 65 mm Hg through MAP support and CSF drainage, comparing outcomes with an 86-patient historical cohort. Protocol adherence was difficult, CSF drainage did not meaningfully alter intrathecal pressure or SCPP, and neurologic recovery did not differ. Six adverse events were considered probably intervention-related. The study does not disprove the importance of local perfusion pressure; it shows that lumbar drainage is not yet a validated solution to the local pressure problem in traumatic SCI (Gee et al., 2026). Routine lumbar drainage or SCPP-targeted therapy therefore remains investigational.

Hemodynamic support also cannot substitute for decompression. If bone, disc, hematoma, or malalignment is compressing the cord, raising systemic pressure while leaving the mechanical lesion in place treats only one side of the perfusion equation. The 2024 AO Spine/Praxis guideline recommends offering decompression within 24 hours as the preferred option for adults with acute SCI, regardless of level, when medically feasible. In the pooled evidence informing the recommendation, surgery within 24 hours was associated with greater motor recovery and a higher probability of improving by at least two AIS grades. Evidence for surgery within an even shorter, “ultra-early” window such as 8 or 12 hours remained insufficient because definitions and results were inconsistent (Fehlings et al., 2024).

The recommendation is not uncontested. The AANS and CNS issued a 2024 position statement arguing that the available literature remains heterogeneous and lacks prospective class I evidence sufficient to dictate a universal operative deadline. They emphasized the neurologic syndrome, the cause and degree of compression, spinal stability, comorbidities, anticoagulants, associated injuries, and the availability of an appropriate surgical team (AANS/CNS, 2024). The correct synthesis is not that timing is irrelevant. Avoidable delay should be treated as harmful, and the spine surgeon should be engaged as soon as SCI is suspected. At the same time, the 24-hour window does not supersede control of exsanguinating hemorrhage, correction of immediately lethal physiology, or the need to perform the right operation safely. “Time is spine” means eliminating remediable delay, not transporting an unstable patient to the operating room to satisfy a clock.

The first-hours endpoint is therefore not simply “admitted to the ICU with MAP greater than 85.” It is a patient whose life-threatening injuries have been treated, whose pre- and post-resuscitation neurologic examinations are documented, whose circulation and ventilation are adequate, whose fracture and cord pathology are understood, whose blood-pressure target reflects both current evidence and individual physiology, and whose need for surgery has been resolved without avoidable delay. From that point, the problem changes again. The next phase is the neuro-ICU course after cervical or thoracic SCI, where respiratory muscle failure, secretion clearance, bradyarrhythmias, neurogenic vasoplegia, temperature dysregulation, venous thromboembolism, ileus, bladder dysfunction, pressure injury, and early rehabilitation become the dominant threats to preserved function.